Allergy Therapeutics plc (LON:AGY)‘s stock had its “buy” rating reiterated by research analysts at FinnCap in a research report issued to clients and investors on Friday. They presently have a GBX 43 ($0.54) target price on the stock. FinnCap’s target price indicates a potential upside of 70.30% from the company’s current price. Several other analysts […]
